Mostafa Bahaa

• NCT06995339

  Phase 2, Completed, 60 people, 29 May 2025

• NCT06924658

  Phase 2, Recruiting, 70 people, 11 Apr 2025

• NCT06762314

  Phase 2, Completed, 114 people, 7 Jan 2025

• NCT06329882

  Phase 1/2, Completed, 60 people, 26 Mar 2024

• NCT06301178

  Phase 1/2, Completed, 35 people, 8 Mar 2024

• NCT06231745

  Phase 3, Completed, 100 people, 30 Jan 2024

• NCT06231758

  Phase 3, Recruiting, 70 people, 30 Jan 2024

• NCT06201793

  Phase 2, Completed, 46 people, 11 Jan 2024

• Montelukast in Parkinson Disease

  Phase 2/3, Completed, 60 people, 2 Nov 2023

• NCT05986136

  Phase 2/3, Completed, 60 people, 14 Aug 2023

• NCT05962957

  Phase 2, Completed, 80 people, 27 Jul 2023

• NCT05638880

  Phase 2, Completed, 60 people, 6 Dec 2022

• NCT05637086

  Phase 2, Recruiting, 90 people, 5 Dec 2022

Sources: clinicaltrials.gov